Biological activity of 1-arylethylphosphonic acids

Pharmaceutical Chemistry Journal

Volumn 37, Issue 5, 2003, Pages 226-228

  Bondarenko, N A ^a   Lermontova, I N ^b   Bondarenko, G N ^c   Gulyukina, N S ^c   Dolgina, T M ^c   Bachurin, S O ^b   Beletskaya, I P ^c  

^a Emotional Stress Pharmaco Devmt   (Russian Federation)

^b INSTITUTE OF PHYSIOLOGICALLY ACTIVE COMPOUNDS   (Russian Federation)

^c MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

1 (1 NAPHTHYL)ETHYLPHOSPHONIC ACID; 5 HYDROXYTRYPTOPHAN; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; ETHYLPHOSPHONIC ACID DERIVATIVE; GLUTAMIC ACID; LEVODOPA; POTASSIUM; TRIFLUOPERAZINE; UNCLASSIFIED DRUG; VINYLPHOSPHONIC ACID DERIVATIVE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM TRANSPORT; CELL CULTURE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG ACTIVITY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG POTENTIATION; DRUG SYNTHESIS; IN VITRO STUDY; MOTOR ACTIVITY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; RAT; SEROTONINERGIC SYSTEM; STEREOTYPY; STRESS; SYNAPTOSOME;

EID: 0242551409     PISSN: 0091150X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1025374321522     Document Type: Article

References (13)

1. C. Bellucci, F. Gualtieri, S. Scapecchi, et al., Farmaco, 44(12), 1167-1191 (1989).
2. K. W. Jung, K. D. Janda, P. J. Sanfilippo, and M. Wachter, Bioorg. Med. Chem. Lett., 6(19), 2281-2282 (1996).
3. C.-H. L. Lo, P. Wentworth, K. W. Jung, et al., J. Am. Chent. Soc., 119(42), 10251-10252 (1997).
4. Data, P. Wentworth, J. P. Shaw, et al., J. Am. Chem. Soc., 121(45), 10461-10467 (1999).
5. N. S. Gulyukina, T. M. Dolgina, G. N. Bondarenko, et al., Zh. Org. Khim., 38(4), 600-613 (2002).
6. N. A. Bondarenko, Byul. Éksp. Biol., No. 11, 506-508 (1990).
7. K. S. Rayevsky, N. A. Bondarenko, et al., Ann. 1st. Super. Sanita, 26(1), 25-30 (1990).
8. N. A. Bondarenko, L. Baran, and A. Klodzinska, Byul. Éksp. Biol., No. 12, 627-628 (1990).
9. A. Campbell, R. J. Baldessarini, et al., Neuropharmucology, 23(7A), 725-730 (1984).
10. V. Gallo, B, Kingsbury, R. Balazs, R. J. Jorgensen, Neuroscience, 7, 2203-2213 (1987).
11. N. N. Lermontova, A. E. Redkozubov, E. F. Shevtsova, et al., Byul. Éksp. Biol., No. 11, 545-550 (2001).
12. R. Schwarcz, A. C. Foster, E. D. French, et al., Life Sci., 35(1), 19-32 (1984).
13. T. Walsh and K. Opello, in: Toxin-Induced Models of Neurological Disorders, M. L. Woodruff and A. J. Nonneman (eds.), Plenum Press, New York - London (1994), pp. 259-279.